Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines

Published:2008-01-14 Issue:19 Volume:27 Page:2737-2745
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Sasaki H,Hayakawa J,Terai Y,Kanemura M,Tanabe-Kimura A,Kamegai H,Seino-Noda H,Ezoe S,Matsumura I,Kanakura Y,Sakata M,Tasaka K,Ohmichi M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1210926.pdf

Reference38 articles.

1. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H et al. (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291: 1701–1712.

2. Bardin A, Hoffmann P, Boulle N, Katsaros D, Vignon F, Pujol P et al. (2004). Involvement of estrogen receptor beta in ovarian carcinogenesis. Cancer Res 64: 5861–5869.

3. Berns EM, Klijn JG, Henzen-Logmans SC, Rodenburg CJ, van der Burg ME, Foekens JA . (1992). Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer. Int J Cancer 52: 218–224.

4. Cauley JA, Norton L, Lippman ME, Eckert S, Krueger KA, Purdie DW et al. (2001). Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast Cancer Res Treat 65: 125–134.

5. Celano P, Berchtold C, Casero R . (1989). A simplification of the nuclear run-off transcription assay. Biotechniques 7: 942–944.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond breast cancer: role of selective estrogen receptor modulators in reducing systemic malignancies: evidence from population-based data;Current Medical Research and Opinion;2024-08-18

2. The multifaceted therapeutic value of targeting steroid receptor coactivator-1 in tumorigenesis;Cell & Bioscience;2024-03-29

3. Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer;Journal of Cancer Research and Clinical Oncology;2023-05-02

4. Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer;2023-02-13

5. The Role of Cow’s Milk Consumption in Breast Cancer Initiation and Progression;Current Nutrition Reports;2023-02-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3